Skip to main content
Equibles

BARCLAYS PLC

Position in MRNA — Moderna, Inc.

CIK 312069 LONDON, X0
Back to MRNA Full portfolio

Position in MRNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$72,489,872
+$25,130,608 QoQ
Shares Held
1,035,126
+11.0% QoQ
Ownership
0.259%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#34
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$43,607,681
PutShares
622,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,706,204,586 across 455 Biotechnology names. MRNA ranks #5 (4.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 733,274 $364,239,192
2 REGN
Regeneron Pharmaceuticals, Inc.
 256,192 $159,745,957
3 IONS
Ionis Pharmaceuticals Inc
 1,603,136 $127,112,653
4 ARGX
Argenx SE
 134,427 $124,717,337
5 MRNA
Moderna, Inc.
This page 		1,035,126 $72,489,872
6 BBIO
BridgeBio Pharma, Inc.
 714,423 $53,210,224
7 TGTX
Tg Therapeutics, Inc.
 957,848 $52,624,168
8 DNTH
Dianthus Therapeutics, Inc. /DE/
 431,753 $42,087,281

All Filings in MRNA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $72,489,872 1,035,126
2026-06-30 $43,607,681 622,700
2026-03-31 $6,096,000 120,000
2026-03-31 $965,200 19,000
2026-03-31 $47,359,264 932,269
2025-12-31 $45,487,055 1,542,457
2025-12-31 $10,359,837 351,300
2025-12-31 $17,434,488 591,200
2025-09-30 $7,911,729 306,300
2025-09-30 $4,447,926 172,200
2025-09-30 $52,068,835 2,015,828
2025-06-30 $33,108 1,200
2025-06-30 $60,345,591 2,187,227
2025-06-30 $5,691,817 206,300
2025-03-31 $4,876,200 172,000
2025-03-31 $40,364,075 1,423,777
2025-03-31 $4,371,570 154,200
2024-12-31 $49,727,140 1,195,939
2024-12-31 $3,534,300 85,000
2024-09-30 $1,336,600 20,000
2024-09-30 $102,437,822 1,532,812
2024-09-30 $1,336,600 20,000
2024-06-30 $32,383,125 272,700
2024-06-30 $159,095,666 1,339,753
2024-03-31 $127,115,101 1,192,897
2024-03-31 $2,131,200 20,000
2024-03-31 $2,131,200 20,000
2023-12-31 $15,782,715 158,700
2023-12-31 $110,206,909 1,108,164
2023-09-30 $97,598,719 944,900
2023-06-30 $110,673,376 910,892
2023-03-31 $100,533,005 654,597
2023-03-31 $40,714,058 265,100
2023-03-31 $65,256,142 424,900
2022-12-31 $161,083,216 896,800
2022-12-31 $96,330,206 536,300
2022-12-31 $263,727,063 1,468,250
2022-09-30 $187,864,246 1,588,704
2022-06-30 $77,810,395 544,700
2022-06-30 $67,953,745 475,700
2022-06-30 $169,884,361 1,189,250
2022-03-31 $226,378,406 1,314,167
2021-12-31 $600,637,302 2,364,900
2021-12-31 $838,672,180 3,302,119
2021-09-30 $33,983,138 88,300
2021-09-30 $482,999,683 1,255,001
2021-06-30 $13,675,836 58,200
2021-06-30 $140,448,013 597,702
2021-03-31 $6,547,500 50,000
2021-03-31 $54,038,871 412,668

Report a Problem

Category
Description
Email (optional, for follow-up)